Companion Animal Pharmaceuticals Global Market Report 2024

Description

Companion Animal Pharmaceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on companion animal pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for companion animal pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The companion animal pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Animal Type: Dogs; Cats; Horses; Other Companion Animals
2) By Indication: Infectious Diseases; Dermatologic Diseases; Pain; Orthopedic Diseases; Behavioral Diseases; Other Indications
3) By Distribution Channels: Veterinary Hospitals; Veterinary Clinics; Retail Pharmacies
Companies Mentioned: Elanco Animal Health Incorporated; Boehringer Ingelheim International GmbH; Ceva Sante Animale; Chanelle Pharma; Eco Animal Health Group PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Companion animal pharmaceuticals involve the pharmaceutical medication process where animal pharmacists recommend medications, fill prescriptions, and manage drug therapies for animals. It is utilized in the diagnosis, mitigation, and treatment of various diseases in animals.

The main types of companion animal pharmaceuticals include medications for dogs, cats, horses, and other companion animals. Dogs are highly variable carnivorous domesticated mammals closely related to the common wolf. The indications for these pharmaceuticals cover infectious diseases, dermatologic diseases, pain management, orthopedic diseases, behavioral issues, and other conditions. These medications are typically sold through various distribution channels such as veterinary hospitals, veterinary clinics, and retail pharmacies.

The companion animal pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides companion animal pharmaceuticals market statistics, including companion animal pharmaceuticals industry global market size, regional shares, competitors with a companion animal pharmaceuticals market share, detailed companion animal pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal pharmaceuticals industry. This companion animal pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The companion animal pharmaceuticals market size has grown strongly in recent years. It will grow from $15.23 billion in 2023 to $16.63 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period of companion animal pharmaceuticals can be attributed to factors such as the humanization of pets, increased focus on preventive healthcare measures for animals, a rise in pet insurance adoption, changing lifestyles and urbanization leading to increased pet ownership, and growing concerns about zoonotic diseases. Additionally, improved accessibility to veterinary healthcare services has played a role in the historical growth of the companion animal pharmaceuticals market.

The companion animal pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $24.2 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The forecasted growth in the companion animal pharmaceuticals market can be attributed to trends such as the adoption of personalized medicine for pets, the integration of telehealth and remote veterinary services, a growing focus on nutrition and nutraceuticals for animals, the promotion of One Health initiatives, and the expansion of veterinary diagnostic services. Additionally, major trends in the forecast period include ongoing advancements in veterinary medicine, the development of specialized therapeutics for aging pets, a focus on regulatory compliance and safety standards, and increased collaborations and partnerships within the industry.

The rising incidence of zoonotic diseases is anticipated to drive growth in the companion animal pharmaceuticals market. Zoonotic illnesses, capable of transmission between vertebrate animals and humans, present a considerable public health challenge. In response, the pharmaceutical industry is deploying modern strategies aligned with health principles to combat these diseases and reduce transmission risks. A December 2022 report by the European Centre for Disease Prevention and Control underscores the increasing prevalence of Campylobacteriosis and other zoonotic diseases, highlighting the need for pharmaceutical interventions.

The companion animal pharmaceutical market is poised for growth, fueled by an upsurge in pet ownership. Pet ownership, signifying the human assumption of responsibility for animal care, is on the rise. The market benefits from an expanding pet owner base and a growing recognition of the importance of preventive measures, diagnostics, and treatments for companion animal health. A report from the American Veterinary Medical Association in October 2022 reveals a substantial increase in families owning at least one cat. The trend, supported by increased veterinary spending, underscores the market's growth potential.

The adoption of big data technologies is a noteworthy trend in the companion animal pharmaceuticals sector. Leading companies are actively developing technological solutions to fortify their market positions. Notably, Elanco Animal Health Incorporated and Ginkgo Bioworks launched BiomEdit in April 2022. This microbiome innovation company focuses on developing novel probiotics and related animal pharmaceuticals. The initiative extends to areas such as medicated feed ingredients, nutritional health, therapies for livestock and pets, and biosecurity technologies for monitoring animal illnesses.

Major players in the companion animal pharmaceutical market are introducing innovative products to cater to larger customer bases and boost revenue. Oral flea and tick products, administered by mouth to prevent or treat infestations in pets, have gained prominence. Elanco Animal Health Incorporated's May 2021 launch of Credelio Cat, the first oral flea and tick product for cats, exemplifies this trend. The product's rapid efficacy, starting within six hours, coupled with its sustained potency, addresses a critical need in the market for efficient and lasting protection against fleas and ticks.

In July 2022, Dechra Pharmaceuticals completed the acquisition of Piedmont Animal Health for $210 million. This strategic move enhances Dechra's product portfolio for European and North American markets and augments its scientific and regulatory capabilities. Piedmont Animal Health, a US-based company specializing in companion animal pharmaceuticals, brings complementary offerings to further strengthen Dechra's position in the industry.

Major companies operating in the companion animal pharmaceuticals market report are Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma, Eco Animal Health Group PLC, Ashish Life Science Pvt. Ltd., Endovac Animal Health, Hipra Laboratories, Indian Immunologicals Ltd., Inovet Group, Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Laboratories Ltd., Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Agrolabo S.p.A., ALS Pvt. Ltd., Zydus Animal Health and Investments Limited, Eli Lilly and Company, IDEXX Laboratories Inc., Merial Limited, Novartis Animal Health Inc., Dechra Pharmaceuticals PLC, Aratana Therapeutics Inc., Phibro Animal Health Corporation, Kindred Biosciences Inc., Jaguar Health Inc., Nexvet Biopharma PLC, Sentinel Biomedical Inc., PetMed Express Inc., Neogen Corporation, Heska Corporation, Synbiotics Corporation, Eurovet Animal Health B.V., Vironova AB, Abaxis Inc., Bioiberica S.A.U., Putney Inc., Lohmann Animal Health International

North America was the largest region in the companion animal pharmaceuticals market in 2023. Asia-Pacific is expected to be the fastest-growing region in the companion animal pharmaceuticals market report during the forecast period. The regions covered in the companion animal pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the companion animal pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The companion animal pharmaceuticals market includes revenues earned by entities by providing veterinary pharmaceuticals, vaccines, and health management tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12570

1. Executive Summary

2. Companion Animal Pharmaceuticals Market Characteristics

3. Companion Animal Pharmaceuticals Market Trends And Strategies

4. Companion Animal Pharmaceuticals Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Companion Animal Pharmaceuticals Market Size and Growth

5.1. Global Companion Animal Pharmaceuticals Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Companion Animal Pharmaceuticals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Companion Animal Pharmaceuticals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Companion Animal Pharmaceuticals Market Segmentation

6.1. Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Dogs
Cats
Horses
Other Companion Animals
6.2. Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other Indications
6.3. Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Veterinary Hospitals
Veterinary Clinics
Retail Pharmacies

7. Companion Animal Pharmaceuticals Market Regional And Country Analysis

7.1. Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Companion Animal Pharmaceuticals Market

8.1. Asia-Pacific Companion Animal Pharmaceuticals Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Companion Animal Pharmaceuticals Market

9.1. China Companion Animal Pharmaceuticals Market Overview
9.2. China Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Companion Animal Pharmaceuticals Market

10.1. India Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Companion Animal Pharmaceuticals Market

11.1. Japan Companion Animal Pharmaceuticals Market Overview
11.2. Japan Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Companion Animal Pharmaceuticals Market

12.1. Australia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Companion Animal Pharmaceuticals Market

13.1. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Companion Animal Pharmaceuticals Market

14.1. South Korea Companion Animal Pharmaceuticals Market Overview
14.2. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Companion Animal Pharmaceuticals Market

15.1. Western Europe Companion Animal Pharmaceuticals Market Overview
15.2. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Companion Animal Pharmaceuticals Market

16.1. UK Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Companion Animal Pharmaceuticals Market

17.1. Germany Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Companion Animal Pharmaceuticals Market

18.1. France Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Companion Animal Pharmaceuticals Market

19.1. Italy Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Companion Animal Pharmaceuticals Market

20.1. Spain Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Companion Animal Pharmaceuticals Market

21.1. Eastern Europe Companion Animal Pharmaceuticals Market Overview
21.2. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Companion Animal Pharmaceuticals Market

22.1. Russia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Companion Animal Pharmaceuticals Market

23.1. North America Companion Animal Pharmaceuticals Market Overview
23.2. North America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Companion Animal Pharmaceuticals Market

24.1. USA Companion Animal Pharmaceuticals Market Overview
24.2. USA Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Companion Animal Pharmaceuticals Market

25.1. Canada Companion Animal Pharmaceuticals Market Overview
25.2. Canada Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Companion Animal Pharmaceuticals Market

26.1. South America Companion Animal Pharmaceuticals Market Overview
26.2. South America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Companion Animal Pharmaceuticals Market

27.1. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Companion Animal Pharmaceuticals Market

28.1. Middle East Companion Animal Pharmaceuticals Market Overview
28.2. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Companion Animal Pharmaceuticals Market

29.1. Africa Companion Animal Pharmaceuticals Market Overview
29.2. Africa Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Companion Animal Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Companion Animal Pharmaceuticals Market Competitive Landscape
30.2. Companion Animal Pharmaceuticals Market Company Profiles
- 30.2.1. Elanco Animal Health Incorporated
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Boehringer Ingelheim International GmbH
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Ceva Sante Animale
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Chanelle Pharma
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Eco Animal Health Group plc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Companion Animal Pharmaceuticals Market Competitive Benchmarking

32. Global Companion Animal Pharmaceuticals Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Companion Animal Pharmaceuticals Market

34. Companion Animal Pharmaceuticals Market Future Outlook and Potential Analysis

34.1 Companion Animal Pharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
34.2 Companion Animal Pharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
34.3 Companion Animal Pharmaceuticals Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer